Universal Quantum
Modular trapped-ion quantum computers built by connecting small quantum chips.
>$100MSeries A
LeadD
DCVC
Activity from announced rounds
Activity in this selectionUnited Kingdom · Oct 12, 2026 · Jan 1, 2026
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $260M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionCallosum
Software infrastructure allowing AI workloads to run across different chips and models
$100MSeed
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosed